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IN human orthotopic liver transplantation (LTX) intra-
operative elevations of TNF-t (> 100 pg]ml) and IL-6
(>800 pg/ml) have been found to correlate with early
post-operative rejections and infections respectively. In
this study the possible mechanism responsible for the
induction of these cytokines has been investigated during
liver allografting in 38 recipients. Intraoperative elevations
of TNF-t (> 100 pg/ml) were detected in the majority of
pre-transplant endotoxin positive recipients (8/12, > 10
endotoxin units/ml), the patients turning endotoxin posi-
tive until the end of grafting (3/5), and in a subgroup (6/21
patients), apparently endotoxin negative for the whole
operation. Therefore endotoxin (ET) seems to stimulate
release of TNF-t in approximately 50% of the patients,
whereas sensitized Kupffer graft cells or immediate allo-
graft reactivity of the host are likely to account for the
remaining TNF-t positive cases. Elevations of IL-6 > 800
pg/ml) were found in approximately 50% of the TNF-t
positive cases, indicating partially independent regulatory
pathways for IL-6 induction in the TNF-0t negative pa-
tients. In agreement with a previous study, 11/13 (85%) of
the intraoperative TNF-t positive recipients rejected their
grafts within the first 10 days post-operatively. These data
demonstrate that ET/infection associated as well as ET
independent/reperfusion associated intraoperative TNF-x
elevations, promote the initiation of allograft rejection in
human liver transplantation. The transient and low en-
dotoxaemia caused by the liver grafting procedure per-
formed without veno-venous bypass seems to be of minor
importance in the intraoperative induction of TNF-t.
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Introduction
Orthotopic liver transplantation is an accepted
therapy for end-stage liver disease with high graft
survival in properly selected patients. However,
primary nonfunction of the graft, frequent
rejections, post-operative multi-organ complica-
tions, infections and further complications caused
by the underlying diseases are observed in the
majority of the recipients.
2 With the exception of
primary nonfunction, surgical problems and acute
drug toxicity, the diverse biological and patholog-
ical responses in patients with post-operative
complications are correlated with elevated systemic
and local levels of cytokines, as TNF-, IL-1, IL-6,
IL-8 and others.
3 Clinical and animal experimental
liver transplantations are associated with systemic
circulation of intestine derived endotoxin during
recirculation after the anhepatic phase, possibly
resulting in release of TNF-0 and various other
kinds of cytokines and toxic mediators from
Kupffer cells and alveolar macrophages.
4 High
peripheral blood concentrations of TNF-0 were
found in clinical allograft rejection, septic shock and
hepatopulmonary damage in experimental animal
models, Anti-TNF-0 antibodies were demon-
strated to prolong graft survival, reverse rejections
and to diminish the hepatic and pulmonary damage,
providing clear evidence for the direct functional
participation of TNF-cz in graft damage and
inflammation. 5’6
In a previous study we measured the courses of
ET, TNF-0 and IL-6 plasma concentrations during
human liver transplantation and correlated in-
traoperative elevations of TNF- with subsequent
rejections and those of IL-6 with post-operative
infectious complications in a high percentage of the
recipients in a multivariate analysis.
7,s Furthermore
detailed analysis of IL-6 in the pulmonal and radial
artery and the femoral vein during LTX revealed
the preferential production of IL-6 in resident lung
macrophages in patients who developed infections
in the early post-operative phase. In these studies
no direct correlation of intraoperative endotox-
aemia with post-operative complications was
observed.
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In the present study the role of endotoxin in the
induction of TNF-0 and 1L-6 was investigated in a
larger group of liver transplant recipients. Al-
though in selected animal models, ET was
demonstrated to induce the typical pathophysio-
logical changes associated with the liver grafting
procedure, the situation in clinical liver transplanta-
tion with patients of widely different qualitative and
quantitative liver impairment, variable length of the
anhepatic phase, variations in MHC disparity and
variable organ conservation, is expected to be much
more complex.
Patients, Materials and Methods
Patients: Thirty-eight orthotopic liver transplanta-
tions (LTX; two retransplantations) in 38 patients
carried out at our institution between August 1990
and June 1991 were included in this study. The
mean age of the patients (twelve females, 26 males)
was 47 q-14 years (range, 16-67 years) and
indication for LTX was tumour in six (hepato-
cellular carcinoma, liver metastases), fulminant
hepatitis in one, primary biliary cirrhosis in five,
alcoholic liver cirrhosis in nine, Wilson’s disease in
two, cirrhosis (cryptogenic, post-hepatic and sec-
ondary biliary) in 13, and retransplantation after
graft failure due to rejection in two cases. All
recipient-donor pairs were matched for blood
group compatibility, but not for their major
histocompatibility antigens (two to three HLA
mismatches). Liver grafting was performed as
described previously.
7 Immunosuppressive therapy
was initiated with methylprednisolone at the end of
the operation, followed by an anti-thymocyte
globulin preparation (ATG; Bio-Merrieux, France)
preparation beginning on the second day post-
transplant (200 mg/day) and finally after 8 days by
cyclosporine/prednisolome maintenance therapy
(aimed at 150-250 ng/ml CsA blood trough level as
measured by HPLC; prednisolone tapered from
200 mg/day to 40 mg/day). Diagnosis of infection
was based on bacteriological cultures from blood
samples, urine, bile or ascites for baeterial infections
and on virus isolation cultures from blood, urine
and sputum and serology for viral infections.
Rejections were diagnosed by clinical signs,
increases in blood concentrations of bilirubin, liver
enzymes and histological examination of liver
biopsies (grade I-IV).
During transplantation, blood samples (3-5 ml)
were drawn into heparinized tubes at the
following time points" (a) immediately before
operation; (b) before clamping of liver vessels; (c)
at the beginning of the anhepatic phase; (d) at
end of the anhepatic phase; (e) 5 min after
recirculation; and (f) at the end of the operation.
Blood was collected from the radial artery for all
time points. Duration of the anhepatic phase was
approximately 65 min, ranging from 45-145 min.
The blood samples were stored at 4C, centrifuged
and the plasma fraction used in all determinations.
Measurement of endotoxin" Endotoxin was determined
using a commercial Limulus amoebocyte lysate test
system (Coatest Endotoxin; Kabi Diagnostica,
Nykoepping, Sweden; E. coli 0111"B4 endotoxin
standard) and a sample pretreatment method
according to Berger et al. with modifications.
1 In
brief, 0.5 ml plasma was centrifuged in Centrisart I
(Sartorius, Goettingen, Germany) molecular weight
separation tubes (cut-off, 20 kDa; centrifugation for
30 min at 2000 x g,). The fraction > 20 kDa was
made up to a volume of 1 ml with sterile,
pyrogen-free water and proteins precipitated by
addition of 2 ml water-saturated phenol (10 min,
68C). After cooling to 4C the aqueous phase was
collected and the phenolic phase again extracted
with 2 ml of water. The pooled aqueous phases
were centrifuged at 1 500 x g for 30min and
directly assayed in the LAL test in appropriate
dilutions (1"200 to 1"400; test range, 0.1-1.2
EU/ml; 1 endotoxin unit equivalent to 12ng
endotoxin) without further purification. Determina-
tions were done in duplicate in microtitre plates and
false positive samples excluded from analysis.
Cleavage of the S 2423 substrate was assayed at
O.D. 415 nm and the endotoxin concentrations of
the samples were calculated using the standard
samples of the Coatest kit. The cut-off" value (mean
value -+- 2 S.D.) for positive detection of ET was
10 EU/ml in a group of 18 liver graft recipients
without complications at control examinations.
Measurement of tumor necrosis factor-" TNF-0 was
determined with an immunoradiometric assay kit
consisting of precoated capture and tracer mono-
clonal antibodies (TNF-0-IRMA, Medgenix Diag-
nostics, Brussels, Belgium). The test was carried
out according to the manufacturer’s instructions
using plasma samples in duplicate (200 #1 each). The
detection limit of this method is 5 pg TNF-0/ml and
the test range was 5-5000 pg/ml. Normal values
were 5 + 3.5 pg TNF-0/ml in healthy controls
(mean _+ S.D., n-- 16).
Measurement of interleukin-6" IL-6 was determined with
an ELISA-kit (Quantikine IL-6; Research and
Diagnostics System, Minneapolis, MN) with a
precoated monoclonal catcher antibody and an
enzyme-linked polyclonal antibody preparation for
detection of bound IL-6. The detection limit is 5
pg IL-6/ml and the test range 5-2000 pg/ml. No
IL-6 could be detected in plasma samples from
healthy control persons.
Statistical anasis" Differences in mean cytokine
plasma concentrations between different LTX
groups were analysed by Student’s t-tests.
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Results
Intraoperative plasma concentrations of endotoxin" Samples
containing more than 10 EU/ml endotoxin were
regarded as ET positive. According to their
intraoperative courses of ET the graft recipients
were assigned to one of four groups. The patients
found to be ET positive at the beginning of the
transplantation (n 12/38) were further subdivided
in two groups, one remaining ET positive for all
further determinations (group 1, n 6/12) and the
other turning ET negative at the end of graftihg
(group 2, n 6/12). Of the pre-operatively ET
negative patients, 5/26 recipients became ET
positive intraoperatively (group 3) and 21/26 were
again ET negative at the end of the operation,
showing a transient increase (15.9 7.2 EU/ml) in
circulating ET during the anhepatic phase in half
of the cases (Fig. 1). In ET positive patients (group
1), the ET concentrations were further increased
during the anhepatic phase (C-D), dropped upon
recirculation (E) and returned to pre-operative
positive levels at the end of the operation (F; Fig.
1). In patients turning ET positive, the continuous
increase in ET started in the early phase (B) of liver
transplantation and for the two remaining groups
(3 and 4) the highest ET concentrations were found
at the end of the anhepatic phase (observation D).
Intraoperative plasma concentrations of TNF-o and IL-6:
For TNF- 6/38 patients were positive (>100
pg/ml) pre-operatively and exhibited a doubling of
their TNF- plasma concentrations during liver
transplantation (Fig. 2A, group 1), 10/38 recipients
became TNF- positive until the end of grafting
(group 2), and the remaining patients (22/38) were
TNF-0 negative throughout the operation. As
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FIG. 1. Intraoperative course of endotoxin (ET) in four subgroups of liver
transplant recipients (n 38), classified according to their ET plasma
concentrations at the beginning (A) and end (F) of grafting. Group
(n 6), +A +F; group 2 (n 6), +A -F; group 3 (n 5); -A + F;
and group 4 (n=21), -A -F. Blood samples were collected
intraoperatively after incision of the skin (B), at the beginning of the
anhepatic phase (C), at the end of the anhepatic phase (D), 5 rain
following recirculation (E) and at the end of operation (F). Mean values
(-t-S.E.M.) are given as endotoxin units (EU).., Group 1; I, group
2; I-q, group 3; I, group 4.
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FIG. 2. (A): Intraoperative course of TNF-= in patients with permanent
elevations (TNF-I; n= 6), patients with intraoperative induction of
TNF- (TNF-2; n 11 and TNF- negative patients (TNF-3; n 21
during liver transplantation. Mean values (_+S.E.M.) are shown.
Samples were collected at the beginning of the operation (A), after
incision of the skin (B), at the beginning of the anhepatic phase (C), at
the end of the anhepatic phase (D), 5 min following recirculation (E) and
at the end of grafting (F). The differences between groups are significant
(p < 0.05) for all observations for TNF-I, and for E-F for TNF-2 and
TNF-3. (B): Intraoperative course of IL-6 in patients with permanent
elevations (IL-6/I, >800 pg/ml; n 4), intraoperative induction of IL-6
(IL-6/2, n 12) and IL-6 negative recipients. Mean values (___S.E.M.)
are shown. The differences between the IL-6/2 and IL-6/3 groups are
significant (p < 0.02) for D-F.
published previously, the TNF- elevation became
apparent at the initiation of the recirculation (Fig.
2A, group 2, E).v IL-6 was found to be elevated
(> 800 pg/ml) pre-operatively in 4/38 patients (Fig.
2B, group 1), to show increases in 12/38 patients
(group 2) and to remain negative in 22/38 patients
(group 3) during liver grafting.
Intraoperative TNF- and IL-6 induction in the different
endotoxin subgroups: The relationship of ET to TNF-0
and IL-6 variations during liver transplantation are
shown in Table 1 for the individual patients. In the
endotoxin positive subgroup (group 1) TNF-0 and
IL-6 are detectable at high plasma levels in most
patients. This group consists of patients with
fulminant hepatitis, post-hepatic cirrhosis, a case of
retransplantation with infectious complications and
three cases of end-stage cirrhosis. For patients
turning endotoxin negative during transplantation
(group 2), 4/6 patients showed elevated TNF-0
plasma levels, with parallel changes in IL-6 in the
minority of these patients. In the case of induction
of endotoxin during LTX (group 3), TNF-0 is
detectable in some, but not all patients, which in
addition show IL-6 elevations in most cases, and in
the endotoxin negative recipients 6/21 exhibited
elevated TNF- concentrations, with parallel in-
creases in IL-6 in half of the cases.
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Table 1. Intraoperative courses ofTNF- and IL-6 in individual
liver graft recipients, grouped according to their endotoxin
plasma concentrations at the beginning and end of operation
Endotoxin TNF- L-6 Concordant
Group1 (+-*+) +++
(n 6) elev
Group2 (+-) +
(n=6) 3 xelev
group 3 (- +) + +
(n 5) elev
group4 (--) ++ ++ +
(n 21 elev
15x-
+++
elev 83%
elev
+
elev 33%
-+
++
elev 60%
elev
+
52%
++++
elev
10x
The courses of TNF- and L-6 are symbolized for each patient
in corresponding order; recipients with TNF- > 100 pg/ml and
with L-6 > 800 pg/ml at the end of operation (time point F)
were classified as positive; elevated denotes the patients with
permanent intraoperative elevations and the degree of parallel
changes in the cytokines under investigation for individual
patients is shown as percentage of concordance.
Correlation of ear post-operative complications with in-
traoperative ET, TNF- and IL-6: Endotoxin was
detectable in 5/11 patients with rejections, 4/7
patients with infections, 2/2 patients with both
complications and in 6/21 patients with un-
complicated post-operative course. For the latter
group, in 4/6 patients the ET disappeared from the
systemic circulation during liver grafting. With
exception of two patients all recipients with
elevated intraoperative TNF- concentrations sub-
sequently rejected their grafts. Furthermore TNF-
was found in one case of infection and in one case
without complications. In two cases, rejection of
the grafts was found without preceding intraopera-
tive TNF- elevations. IL-6 was elevated in 15/38
patients, 6/8 infections, 3/13 rejections and in 6/21
patients with uncomplicated course.
Discussion
The sequence of events leading ultimately to
allograft destruction has not been fully charac-
terized. The authors have shown that in human
orthotopic liver transplantation graft rejection in
the first 2 weeks is preceded intraoperatively by the
appearance of TNF-0 in the majority of the
respective recipients. 7’8 In addition, intraoperative
elevations of IL-6 plasma concentrations were
correlated with early post-operative infectious
complications.
9 These findings are supported by
reports describing the appearance ofTNF- during
rejections and the eflqcacy of anti-TNF antibodies
in its prevention and reversal, s’6
In this study the possible mechanisms of TNF-
induction during human liver grafting were
investigated by relating the intraoperative course of
this cytokine to that of circulating ET and IL-6 in
individual patients. Clinical and experimental liver
transplantation are known to induce intraoperative
systemic endotoxaemia and, since ET is a highly
potent inducer of TNF- and other mediators in
Kupt:fer cells, alveolar macrophages and monocytes,
this mechanism was held responsible for the
induction of these cytokines, apparently operative
in the pathogenesis of liver/lung injuries and early
graft failures.4’5 This model of ET induced TNF-
production is contradicted for clinical liver
transplantation by our previous findings, failing to
detect a direct correlation between intraoperative
elevations in ET and specific post-operative
complications.
7
In an extension of the earlier studies, we have
therefore tried to analyse the detailed time courses
and correlations of ET and cytokine patterns in
individual patients in a group of 38 liver graft
recipients. According to their ET plasma concentra-
tions at the beginning and the end of transplanta-
tion the recipients were assigned to the ET
negative, ET positive for all intraoperative
observations, ET disappearing and ET induced
subgroups. The cut-off value for ET was 10 EU/ml,
as defined in LTX outpatients without complica-
tions, and the ’ET negative’ subgroup included
patients with low and transient ET elevations
during the anhepatic phase. The primarily ET
positive recipients included patients with acute liver
failure (fulminant hepatitis, graft failure) and
advanced stages of cirrhosis, showing TNF-0 and
IL-6 elevations in most cases. Interestingly, six ET
positive recipients (one case of Wilson’s disease and
five cases with cirrhosis) turned ET negative during
grafting and four of them showed no further signs
of complication in the post-operative phase,
indicating permanent removal of ET by the grafted
liver. Five patients, again with acute liver failure
and advanced cirrhosis, turned ET positive and
21/38 patients exhibited no or only transient and
moderate intraoperative ET elevations.
The recipients with pre-transplant elevations of
ET showed permanent or induced TNF-0 eleva-
tions in the majority of the cases (8/12) and in
patients turning ET positive intraoperatively, 3/5
showed increases in TNF-. Five out of 21 ET
negative patients showed elevations in TNF-
(observation E, > 100 ng/ml) in the absence of any
transient increases of ET during the anhepatic
phase, indicating non-ET associated induction of
TNF-. As described previously the TNF-
positive recipients showed a high rate of early
post-operative rejections (85%; 11/13 patients),
suggesting that TNF- maT be an important
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predisposing factor in alloantigen reactivity,
independent of its mode of induction. Although
TNF- may induce rejection by several direct acting
mechanisms, including promotion of leucocyte
adherence or stimulation of MHC antigen expres-
sion in the allograft, 11’12 our data cannot exclude
indirect effects ofTNF- on the induction of further
cytokines. Intraoperative elevations in IL-6 were
detected in 15/38 patients with 6/15 post-operative
infectious complications. IL-6 seems to precede the
elevations in TNF- and its course parallels that of
TNF- in about half of the patients (21/38),
indicating a TNF--independent regulation in the
remaining recipients.
In summary, the liver graft recipients exhibit
complex patterns of cytokine expression. A group
of patients showed pretransplant elevations of ET
due to the complications associated with the
underlying end-stage liver diseases, accompanied by
permanent production of TNF-0 and a high
incidence of early graft rejections. Non-cleared ET
at the end of grafting was associated with TNF-0
elevations, whereas the transient ET increases
during the anhepatic phase did not result in subse-
quent significant TNF- elevations and clinical com-
plications. Apparently non-ET mediated TNF-
induction was detected in a sub-group of patients
showing a high frequency of graft rejection.
Maximal TNF production of macrophages/mono-
cytes in response to endotoxin/alloantigens needs
approximately 6 h and is apparently too slow to
account for the observed increases during the final
stages of human liver transplantation. Since TNF-z
was elevated after liver transplantation between
syngeneic inbred rats, the liver conservation/
transplantation procedure itself seems to be a
cause of elevated TNF-. In clinical transplantation
increased rates of rejections were reported in
patients with preservation injuries of their grafts
13
and fulminant hepatitis.
14 The ET independent
TNF-0 production during organ preservation/re-
perfusion is likely to represent a mediator of graft
inflammation after recirculation. We failed to detect
IFN-y or IL-4 in plasma samples from eight liver
recipients (IFN-2 RIA and IL-4 ELISA), but local
production and interaction of several cytokines in
TNF- positive patients is likely to occur during
initiation of graft reiection. Prophylactic inhibition
of TNF- by specific antibodies or inhibitors (like
soluble TNF receptors) initiated prior to allograft
exposure may help to prevent the early events
leading to immunological responses and graft
destruction as well as lung/liver .iniury caused by
this cytokine during grafting.
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